性激素在2型糖尿病患者减重所致肥胖变化中的中介作用:Look AHEAD性激素研究
该研究分析Look AHEAD性激素辅助研究2334名2型糖尿病参与者(50%女性),其中822人(47.4%女性)有双能X线吸收扫描数据,用结构方程模型评估第1年雌二醇、睾酮和性激素结合球蛋白变化对第4年肥胖指标的中介效应。结果显示男性中总睾酮和SHBG升高介导了体重、腰围及脂肪百分比增加,女性中生物可利用睾酮降低介导了全身脂肪和瘦体重减少,存在性别特异性中介效应。
要点
- 男性ILJ相关总睾酮第1年升高14.4%,介导第4年体重增加189克(95%CI 65-317)和腰围增加0.135厘米(95%CI 0.19-0.248)。
- 男性SHBG第1年升高24.6%,介导第4年躯干脂肪百分比增加0.082%(95%CI 0.003%-0.174%)和全身脂肪百分比增加0.068%(95%CI 0.001%-0.146%)。
- 女性生物可利用睾酮第1年降低21.8%,介导第4年全身脂肪量减少164克(95%CI -326至-29.3)、全身瘦体重减少115克(95%CI -203.4至-40)和躯干瘦体重减少97.2克(95%CI -156至-45.5)。
核心结论
- 该研究揭示了强化生活方式干预减重所致性激素变化对2型糖尿病患者体成分改变的性别特异性中介效应。
- 需要进一步研究来探索与2型糖尿病患者减重建议中性别差异相关的长期健康结局。
研究设计与样本
- 分析Look AHEAD性激素辅助研究中2334名参与者(50%女性)的数据,其中822人(47.4%女性)有双能X线吸收扫描。
- 使用结构方程模型评估第1年雌二醇、睾酮和性激素结合球蛋白变化对第4年肥胖指标的中介效应,并按性别分层。
主要发现
- 男性中,强化生活方式干预相关总睾酮第1年升高14.4%,介导第4年体重增加189克(95%CI 65-317)和腰围增加0.135厘米(95%CI 0.19-0.248)。
- 男性中,SHBG第1年升高24.6%,介导第4年躯干脂肪百分比增加0.082%(95%CI 0.003%-0.174%)和全身脂肪百分比增加0.068%(95%CI 0.001%-0.146%)。
- 女性中,生物可利用睾酮第1年降低21.8%,介导第4年全身脂肪量减少164克(95%CI -326至-29.3)、全身瘦体重减少115克(95%CI -203.4至-40)和躯干瘦体重减少97.2克(95%CI -156至-45.5)。
局限性
- 需要进一步研究来探索与2型糖尿病患者减重建议中性别差异相关的长期健康结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: In people with type 2 diabetes (T2D), weight loss affects sex hormones (testosterone [T], estradiol [E2], sex hormone-binding globulin [SHBG]) and reduces fat and lean mass differently in women vs men, but the relationship between sex hormones and adiposity changes due to weight loss is not clear. OBJECTIVE: This paper aims to examine the relationships between sex hormones and adiposity changes due to an intensive lifestyle intervention (ILI). METHODS: We analyzed data from 2334 participants (50% female) in the Look AHEAD Sex Hormone Ancillary Study, including a subset of 822 (47.4% female) with dual-energy x-ray absorptiometry scans. Using structural equation modeling, we assessed how changes in E2, T, and SHBG at year 1 (Y1) mediated the effects of ILI on adiposity measures at year 4 (Y4). We stratified by sex to explore sex differences. RESULTS: In men, a 14.4% ILI-associated increase in total T at Y1 mediated increases in weight (189 g; 95% CI, 65-317) and waist circumference (0.135 cm; 95% CI, 0.19-0.248) at Y4. Additionally, a 24.6% increase in SHBG at Y1 mediated increases both in percentage trunk fat (0.082%; 95% CI, 0.003%-0.174%) and percentage whole-body fat (0.068%; 95% CI, 0.001%-0.146%) at Y4. In women, a 21.8% decrease in bioavailable T (BioT) at Y1 mediated decreases in whole-body fat mass (-164; 95% CI, -326 to -29.3), whole-body lean mass (-115 g; 95% CI, -203.4 to -40), and trunk lean mass (-97.2 g; 95% CI, -156 to -45.5) at Y4. CONCLUSION: This study revealed sex-specific mediating effects of sex hormones due to weight loss from ILI on body composition changes in people with T2D. Further research is needed to explore long-term health outcomes related to sex differences in recommendations for weight loss in people with T2D.
引用
- Oyeka CP, He JH, Ma J, et al. Role of Sex Hormones in Mediating Adiposity Changes From Weight Loss in People With Type 2 Diabetes: Look AHEAD Sex Hormone Study. J Clin Endocrinol Metab. 2025. PMID: 40392972. doi:10.1210/clinem/dgaf287
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。